Ana Cebrián (Ana Cebrián Cuenca, Ana Cebrián-Cuenca)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Prostate Cancer

Radical Prostatectomy

Decision Making

Top Venues

Advances in therapy

Journal of clinical medicine

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Lucy A Parker, Juan-Pablo Caballero-Romeu, Elisa Chilet-Rosell, Ildefonso Hernandez-Aguado, Luis Gómez-Pérez, Pablo Alonso-Coello, Ana Cebrián, Maite López-Garrigós, Irene Moral-Pélaez, Elena Ronda, Mercedes Gilabert, Carlos Canelo-Aybar, Ignacio Párraga-Martínez, Mª Del Campo-Giménez, Lumbreras Blanca
Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study). PloS one 19 (5) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Lucy A Parker, Juan-Pablo Caballero-Romeu, Elisa Chilet-Rosell, Ildefonso Hernandez-Aguado, Luis Gómez-Pérez, Pablo Alonso-Coello, Ana Cebrián, Maite López-Garrigós, Irene Moral-Pélaez, Elena Ronda, Mercedes Gilabert, Carlos Canelo-Aybar, Ignacio Párraga-Martínez, Mª Del Campo-Giménez, Lumbreras Blanca
Knowledge and practices regarding prostate cancer screening in Spanish men: The importance of personal and clinical characteristics (PROSHADE study). PloS one 19 (5) (2024)
Manuel Botana, Miguel Camafort, Raquel Campuzano Ruiz, Ana Cebrián, Manuel Gargallo Fernández, Héctor David de Paz, Jennifer Redondo-Antón, Esther Artime, Silvia Díaz-Cerezo, Miriam Rubio-de Santos
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain. Advances in therapy 41 (9) (2024)
Juan J Gorgojo-Martínez, Pedro Mezquita-Raya, Juana Carretero Gómez, Almudena Castro, Ana Cebrián, Alejandra de Torres-Sánchez, María Dolores García-de-Lucas, Julio Nunez, Juan Carlos Obaya, María José Soler, Jose Luis Gorriz Teruel, Miguel Ángel Rubio-Herrera
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of clinical medicine 12 (1) (2022)
Juan J Gorgojo-Martínez, Pedro Mezquita-Raya, Juana Carretero Gómez, Almudena Castro, Ana Cebrián, Alejandra de Torres-Sánchez, María Dolores García-de-Lucas, Julio Nunez, Juan Carlos Obaya, María José Soler, Jose Luis Gorriz Teruel, Miguel Ángel Rubio-Herrera
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of clinical medicine 12 (1) (2022)
Lumbreras Blanca, Lucy Anne Parker, Pablo Alonso-Coello, Javier Mira-Bernabeu, Luis Gomez-Perez, Juan Pablo Caballero-Romeu, Salvador Pertusa-Martínez, Ana Cebrián, Irene Moral-Peláez, Maite López-Garrigós, Carlos Canelo-Aybar, Elena María Ronda-Pérez, Mercedes Guilabert Mora, Antonio Prieto-González, Ildefonso Hernández-Aguado
PROSHADE Protocol: Designing and Evaluating a Decision Aid for Promoting Shared Decision Making in Opportunistic Screening for Prostate Cancer: A Mix-Method Study. International journal of environmental research and public health 19 (15) (2022)
Juan J Gorgojo-Martínez, Pedro Mezquita-Raya, Juana Carretero Gómez, Almudena Castro, Ana Cebrián, Alejandra de Torres-Sánchez, María Dolores García-de-Lucas, Julio Nunez, Juan Carlos Obaya, María José Soler, Jose Luis Gorriz Teruel, Miguel Ángel Rubio-Herrera
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. Journal of clinical medicine 12 (1) (2022)